ExploreWatchlistsPricing
  1. JP-listed companies
  2. TERUMO CORPORATION
  3. Financials
  4. Payments for dividends

TERUMO CORPORATION (4543)

Market cap
¥3.35T
P/E ratio
20.2x
Terumo develops medical devices and solutions for heart treatment, clinical care, and blood technology to support healthcare delivery worldwide.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndPayments for dividends (Million JPY)YoY (%)
Mar 31, 2026-41,291+15.91%
Mar 31, 2025-35,622+11.28%
Mar 31, 2024-32,010+14.73%
Mar 31, 2023-27,900+18.95%
Mar 31, 2022-23,455+10.87%
Mar 31, 2021-21,155+3.16%
Mar 31, 2020-20,507+4.87%
Mar 31, 2019-19,555+23.46%
Mar 31, 2018-15,839+9.10%
Mar 31, 2017-14,518+9.98%
Mar 31, 2016-13,200+19.87%
Mar 31, 2015-11,012

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat